The program, known as Women (Physicians and Scientists) @ Children’s Hospital, or W@TCH, was established in 1999 with a straightforward mission: to support the professional development and advancement of women faculty at the institution. The new report, led by Kashvi Singh and Anitha S. John of the Division of Cardiology at Children’s National, together with colleagues from hospital medicine, pediatric critical care, emergency medicine, and hematology, focuses on one component of that mission, a Women in Leadership curriculum designed and delivered by the W@TCH committee over a five-year period.

The curriculum’s structure reflected a deliberate pedagogical choice. Rather than relying on passive lectures, the organizers built the program around interactive sessions paired with half-day workshops held at the end of each academic year. Topics were selected to address the specific needs of junior faculty, the career stage at which many women physicians and scientists face competing pressures from clinical duties, research expectations, family responsibilities, and the unwritten rules of academic advancement. The end-of-year workshops gave participants extended time to engage with material, practice skills, and build relationships with colleagues they might otherwise rarely meet across departmental lines.

Evaluation of the curriculum relied on post-event surveys in which participants rated aspects of each workshop on a five-point Likert scale, a standard instrument in medical education research that quantifies subjective satisfaction while allowing comparison across events and years. The results were consistent. Attendees rated Women in Leadership events as very effective or highly effective throughout the program’s run. More tellingly, the median satisfaction score rose over time, climbing from 4.5 out of 5 in 2013 to 4.75 out of 5 in 2017. In evaluation research, where scores often plateau or drift downward as novelty fades, a rising trend across five years suggests that the committee was successfully refining content in response to participant feedback.

The study also captured a longer horizon. In a follow-up survey administered in 2024, seven years after the curriculum period ended, 93 percent of respondents expressed interest in more W@TCH-related events. That figure matters because the central weakness of most professional development interventions is durability: enthusiasm measured immediately after a workshop rarely predicts lasting engagement. A demand signal persisting years later indicates that participants continued to see value in the community the program created, not merely in the individual sessions.

The authors frame the Women in Leadership curriculum as one component of a broader institutional initiative rather than a standalone fix. W@TCH, more than 25 years after its founding, remains active across five pillars: mentoring, networking, leadership development, faculty recognition, and advocacy. This breadth is significant from a program-design perspective. Mentoring relationships address individual guidance, networking builds the social capital that influences promotion decisions, recognition counters the visibility gap that affects women’s scholarly reputations, and advocacy targets institutional policy itself. A curriculum alone touches only one of these mechanisms; the sustained architecture appears to be what keeps the program alive.

The technical context for this work is the well-documented disparity structure of academic medicine. Data compiled by the Association of American Medical Colleges have long shown that women are underrepresented among full professors, department chairs, and deans relative to their share of medical school graduates. The causes are multifactorial, encompassing differences in access to sponsorship, unequal distribution of service and teaching loads, promotion timelines that collide with childbearing years, and climates that can be unwelcoming in subtle ways. Interventions therefore need to be evaluated not just on whether participants enjoyed them, but on whether they plausibly address one or more of these mechanisms. The W@TCH report is candid about its scope: it demonstrates feasibility, sustained engagement, and high satisfaction, which are necessary but not sufficient conditions for changing promotion outcomes.

That limitation is worth stating plainly, because it defines the frontier of this research area. The study’s evaluation data are drawn from post-event surveys and a retrospective follow-up, and the authors do not claim that the curriculum by itself increased promotions, grants, or leadership appointments among participants. Measuring such outcomes would require long-term tracking of career trajectories against matched comparison groups, a design that few institutions have implemented. What the report does establish is that a volunteer-driven, committee-run program can maintain quality and demand across many years, which is itself a nontrivial finding. Most diversity and development initiatives are episodic; they launch with funding or enthusiasm and fade within a few grant cycles. W@TCH’s longevity, sustained without reported external funding, suggests that institutional embedding and a dedicated committee structure can substitute for dedicated budget lines.

For other institutions considering similar programs, the report offers several transferable design lessons. First, content should be driven by the articulated needs of junior faculty rather than by what senior leadership assumes those needs are; the authors report that curriculum topics were relevant to participants’ needs, and the rising satisfaction scores are consistent with that alignment. Second, interactive formats and extended workshops appear to outperform passive formats in generating engagement, echoing broader findings in adult learning research. Third, evaluation should be built in from the start, because the Likert-scale survey data collected routinely after each event are what made this retrospective analysis possible at all. Programs that skip systematic evaluation forfeit the ability to demonstrate their value when institutional priorities shift.

The broader significance of the study lies in its reframing of what gender equity work in medicine can look like. Rather than a one-off training or a compliance exercise, the W@TCH model treats the advancement of women faculty as a continuous institutional function, comparable to quality improvement in clinical care: measured iteratively, adjusted based on data, and sustained across leadership transitions. The authors conclude that sustained programs such as W@TCH may serve as important mechanisms to promote the advancement, retention, and leadership development of women in academic medicine. As hospitals and medical schools confront persistent attrition among women physicians and scientists, the evidence from Children’s National suggests that the question is no longer whether such programs can work, but whether institutions are willing to commit to them for decades rather than years. The 93 percent of former participants who still wanted more, a quarter-century after the program began, may be the most persuasive data point of all.

Subject of Research: Evaluation of a women's leadership development curriculum in academic medicine

Article Title: Striving for success: essential skills for women in academic medicine

Article References: Striving for success: essential skills for women in academic medicine. (n.d.). https://doi.org/10.1186/s12909-026-10428-y

Image Credits: AI Generated

DOI: 10.1186/s12909-026-10428-y

Keywords: academic medicine, women in leadership, gender equity, medical education, career development, mentoring, faculty advancement, W@TCH, Children's National Hospital, professional development, leadership training, retention

The core objective of this collaboration is to enhance the understanding of pediatric oncological conditions. By merging Virginia Tech’s cutting-edge technological capabilities and research expertise with Children’s National Hospital’s extensive experience in pediatric patient care, this initiative hopes to unravel the complexities of childhood cancers. This is crucial given the alarming rates of such diagnoses among young patients, which often come with poor prognoses and limited treatment options. The urgency of the work being done through this partnership cannot be overstated, as the implications extend far beyond clinical settings, affecting the lives of families and communities at large.

The statement from Catherine Bollard, who serves as the senior vice president of Children’s National and leads its Center for Cancer and Immunology Research, underscores the mutual commitment both institutions share to revolutionizing pediatric health. She emphasizes that collaborating with a leading research entity like Virginia Tech has allowed them to accelerate discoveries in the field. The belief here is that coupled expertise will transform the landscape of pediatric oncology, leading to the development of novel therapies and potential cures for even the rarest forms of childhood cancers.

Michael Friedlander, vice president for health sciences and technology at Virginia Tech, echoed this sentiment, highlighting that this partnership has deep roots in biomedical research and innovation. The previously launched Children’s National Research & Innovation Campus, located in Washington, D.C., has been a central hub for this endeavor, providing a space dedicated to interdisciplinary research focused exclusively on pediatric health. The expansion of this collaboration comes at a time when Virginia Tech is also expanding its own research capabilities in nearby Alexandria, with an emphasis on integrating artificial intelligence and data analytics into medical research—an approach that aims to make strides in understanding and treating complex diseases.

Given the ambitious nature of this partnership, the initial focus on pediatric cancers, particularly brain tumors, marks a crucial starting point. These malignancies represent some of the most formidable challenges in childhood cancer treatment. By leveraging technological advancements and research infrastructure at Virginia Tech, alongside clinical expertise at Children’s National, they aspire to significantly enhance the understanding of these devastating conditions and thereby improve therapeutic strategies.

The partnership brings forth the potential for significant advancements, specifically through interdisciplinary collaboration that incorporates various fields of study—from computational biology to clinical oncology. Chris Hourigan, director of the Fralin Biomedical Research Institute Cancer Research Center, highlights this commitment to thinking beyond traditional research boundaries. The integration of diverse scientific disciplines reflects a comprehensive approach to addressing the multifaceted challenges posed by cancer, ultimately leading to improved outcomes for patients.

The framework of this partnership positions both institutions at the forefront of pediatric cancer research. The collaboration’s foundation is built on an understanding that cancer impacts not just individual patients, but families and communities. By fostering an environment where innovative thinking and scientific inquiry can flourish, they aim to drive forward the development of testing methods and therapies that may significantly shift the paradigm of care for young patients battling cancer.

It is also important to recognize the need for training the next generation of scientists and physician-scientists. The partnership is committed to cultivating a new cohort of researchers who will be equipped with the necessary skills to address challenges in pediatric oncology. Through hands-on training and mentorship, emerging scientists will be prepared to contribute to breakthroughs in medical research and clinical practices, ensuring the sustainability of advancements in pediatric health.

As this partnership continues to evolve, each breakthrough in research could present new avenues for treatment that are more effective and less invasive. The distinct advantage offered by combining clinical insight with research expertise serves to pave the way for novel approaches and paradigms that may drastically improve survival rates and quality of life for young patients battling cancer.

The collaborative efforts also include the development of new diagnostic and therapeutic tools that will directly improve the care and management of childhood cancers. The partnership identifies a clear pathway toward the creation of technological solutions that can facilitate more precise diagnoses, leading to tailored treatment strategies. These advancements are particularly critical given the unique biological characteristics of pediatric cancers, which often differ markedly from adult forms of the disease.

Ultimately, the impact of the Children’s National Hospital and Virginia Tech collaboration stretches even further, promising to influence the broader scientific community. As the research yields new insights and establishes successful frameworks for treatment, the findings will be shared with other institutions and clinical practices, enhancing the collective understanding of pediatric cancers and ushering in a new era of innovation in the field.

A successful alliance such as this can catalyze a cultural shift in how pediatric health issues are approached and managed. The collaboration not only strengthens the institutions involved but also contributes to a global dialogue on improving health outcomes for children. The focus on interdisciplinary collaboration, innovative research methodologies, and the commitment to training the next generation of health leaders positions this partnership as a model for future collaborative ventures aiming to tackle complex health challenges in innovative ways.

As these initiatives unfold, continuous engagement with the wider community is essential. Sharing knowledge, resources, and innovative techniques will ensure that the benefits of the research conducted reach beyond the walls of the partner institutions, creating a ripple effect that enhances pediatric health on a much larger scale.

In the realm of pediatric oncology, where the stakes are exceptionally high, this partnership not only signifies a commitment to pushing boundaries but also embodies a collective hope for more effective treatments, longer survival rates, and ultimately a world where childhood cancers are no longer a death sentence.

Subject of Research: Pediatric Cancers
Article Title: Expanding Horizons in Pediatric Oncology: The Collaborative Efforts of Children’s National Hospital and Virginia Tech
News Publication Date: October 2023
Web References: N/A
References: N/A
Image Credits: N/A

Keywords: Pediatric cancer, Interdisciplinary research, Medical innovation, Pediatric health, Cancer treatment, Research collaboration, Biomedical research, Virginia Tech, Children’s National Hospital, Cancer diagnostics, Therapeutic advancements, Training in science.